Regina A. Ivanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Regina A. Ivanova has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Natalia V. Rogozina
Federal Scientific and Clinical Center for Infectious Diseases of the FMBA of Russia
8 shared publications - A. A. Grineva
Pediatric Research and Clinical Center for Infectious Diseases
4 shared publications - G. M. Ushakova
Pediatric Research and Clinical Center for Infectious Diseases
4 shared publications - Valery V. Vasiliev
Pediatric Research and Clinical Center for Infectious Diseases; North-Western State Medical University named after I.I. Mechnikov
4 shared publications - Васильев Валерий Викторович
Северо-Западный государственный медицинский университет им. И.И. Мечникова; Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства
4 shared publications - E. L. Sitkina
Pavlov University
2 shared publications
Latest Publications
- Open Access
- 8 January 2025
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 29 (1) , 35-44
Some Serologic Markers of Toxoplasma gondii, Cytomegalovirus and Rubella Virus in Pregnant Women in Saint Petersburg
BACKGROUND: Currently, research investigating specific immunity to various TORCH pathogens (Toxoplasma gondii, cytomegalovirus, rubella virus) in pregnant women remains relevant. AIM: The aim of the study was to evaluate the detection rates of the main serologic markers of TORCH in pregnant women in Saint Petersburg, Russia. METHODS: A retrospective analysis of the screening of pregnant women (n = 6605) was performed for the presence and levels of specific anti-Toxoplasma gondii, anti-rubella, and anti-cytomegalovirus immunoglobulins M and G in the blood. RESULTS: The rubella seroprevalence rate was 98.2% (n = 4428), with the highest number of seronegative women in the age group of 31 to 35 years. In 8.4% of cases, the serum level of anti-rubella immunoglobulin G was below the protective level. Anti-cytomegalovirus immunoglobulin G was found in 1632 (81.9%) pregnant women, with a significant age-related increase in the number of seropositive women (p 0.001). Specific anti-Toxoplasma gondii immunoglobulin G was found in 28% (n = 1375) of pregnant women. The percentage of seropositive women also increased with age (p 0.001), with the highest level reported in women aged 40 years (40.74%). CONCLUSION: The high level of rubella seroprevalence in pregnant women suggests that testing for anti-rubella antibodies should be performed only in the second trimester. Anti-cytomegalovirus screening is recommended for pregnant women with known risk factors for congenital cytomegalovirus infection. It is recommended to continue anti-Toxoplasma gondii screening because of the high percentage of Toxoplasma gondii seronegative pregnant women in Russia.
- 8 January 2025
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 29 (1) , 35-44
Open AccessSome Serologic Markers of Toxoplasma gondii, Cytomegalovirus and Rubella Virus in Pregnant Women in Saint Petersburg
BACKGROUND: Currently, research investigating specific immunity to various TORCH pathogens (Toxoplasma gondii, cytomegalovirus, rubella virus) in pregnant women remains relevant. AIM: The aim of the study was to evaluate the detection rates of the main serologic markers of TORCH in pregnant women in Saint Petersburg, Russia. METHODS: A retrospective analysis of the screening of pregnant women (n = 6605) was performed for the presence and levels of specific anti-Toxoplasma gondii, anti-rubella, and anti-cytomegalovirus immunoglobulins M and G in the blood. RESULTS: The rubella seroprevalence rate was 98.2% (n = 4428), with the highest number of seronegative women in the age group of 31 to 35 years. In 8.4% of cases, the serum level of anti-rubella immunoglobulin G was below the protective level. Anti-cytomegalovirus immunoglobulin G was found in 1632 (81.9%) pregnant women, with a significant age-related increase in the number of seropositive women (p 0.001). Specific anti-Toxoplasma gondii immunoglobulin G was found in 28% (n = 1375) of pregnant women. The percentage of seropositive women also increased with age (p 0.001), with the highest level reported in women aged 40 years (40.74%). CONCLUSION: The high level of rubella seroprevalence in pregnant women suggests that testing for anti-rubella antibodies should be performed only in the second trimester. Anti-cytomegalovirus screening is recommended for pregnant women with known risk factors for congenital cytomegalovirus infection. It is recommended to continue anti-Toxoplasma gondii screening because of the high percentage of Toxoplasma gondii seronegative pregnant women in Russia.
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (1)
Acute norovirus gastroenteritis: epidemiology, clinical features, treatment and prevention
Achievements in the coverage of the child population with rotavirus vaccination in many countries have led to the fact that norovirus infection (NVI) is rapidly leading to the incidence of acute intestinal infections. NVI affects not only children but also the elderly, as well as patients with reduced immunity. NVI leads to a large number of hospitalizations and deaths, even though, in general, outbreaks of norovirus gastroenteritis are not severe and self-limited. Nevertheless, NVI's social and economic burden cannot be underestimated due to its ability to spread quickly and involve many patients, causing outbreaks in social institutions, schools, hospitals, and nursing homes. Thus 2023, 269 foci of group incidence of NVI were registered in the Russian Federation. The article presents the latest data on the epidemiology of NVI and the prevalence of norovirus genotypes; in particular, a sharp increase in the GII.17 genotype is noted. It is emphasized that the constant change in the genetic diversity of noroviruses and the emergence of new recombinant variants is a global trend that significantly complicates the creation of effective vaccines. Up-to-date information on the diagnosis and differential diagnosis of NVI is presented. The treatment section is devoted to all aspects of therapy and is based on the latest international and national clinical guidelines. The lack of causal therapy for NVI and the importance of timely administration of pathogenetic treatment, including probiotics, are emphasized. Data from experimental and clinical studies have shown that some probiotic strains, such as Saccharomyces boulardii CNCM I-745, which have an indirect antiviral effect, can significantly reduce the duration of diarrhea in children with acute gastroenteritis and the duration of hospitalization. The prospects for the development of various types of vaccines against norovirus are discussed, including vaccines based on non-replicating virus-like particles (VLP), vaccines based on recombinant adenoviruses, vaccines based on P-particles, and mRNA vaccines that form VLP. Prospects in the ongoing fight against NVI are associated with the development of specific methods of prevention (polyvalent vaccines) and treatment (antiviral drugs, microbiomemodulating therapy), the introduction of effective test systems for rapid diagnostics of NVI into routine practice, as well as genetic and immunological studies that will help to establish the subtle mechanisms of susceptibility to norovirus and the characteristics of the immune response to it. Key words: acute norovirus gastroenteritis, norovirus infection, dehydration, rehydration therapy, intestinal microbiome, probiotics, Saccharomyces boulardii CNCM I-745, children
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (1)
Acute norovirus gastroenteritis: epidemiology, clinical features, treatment and prevention
Achievements in the coverage of the child population with rotavirus vaccination in many countries have led to the fact that norovirus infection (NVI) is rapidly leading to the incidence of acute intestinal infections. NVI affects not only children but also the elderly, as well as patients with reduced immunity. NVI leads to a large number of hospitalizations and deaths, even though, in general, outbreaks of norovirus gastroenteritis are not severe and self-limited. Nevertheless, NVI's social and economic burden cannot be underestimated due to its ability to spread quickly and involve many patients, causing outbreaks in social institutions, schools, hospitals, and nursing homes. Thus 2023, 269 foci of group incidence of NVI were registered in the Russian Federation. The article presents the latest data on the epidemiology of NVI and the prevalence of norovirus genotypes; in particular, a sharp increase in the GII.17 genotype is noted. It is emphasized that the constant change in the genetic diversity of noroviruses and the emergence of new recombinant variants is a global trend that significantly complicates the creation of effective vaccines. Up-to-date information on the diagnosis and differential diagnosis of NVI is presented. The treatment section is devoted to all aspects of therapy and is based on the latest international and national clinical guidelines. The lack of causal therapy for NVI and the importance of timely administration of pathogenetic treatment, including probiotics, are emphasized. Data from experimental and clinical studies have shown that some probiotic strains, such as Saccharomyces boulardii CNCM I-745, which have an indirect antiviral effect, can significantly reduce the duration of diarrhea in children with acute gastroenteritis and the duration of hospitalization. The prospects for the development of various types of vaccines against norovirus are discussed, including vaccines based on non-replicating virus-like particles (VLP), vaccines based on recombinant adenoviruses, vaccines based on P-particles, and mRNA vaccines that form VLP. Prospects in the ongoing fight against NVI are associated with the development of specific methods of prevention (polyvalent vaccines) and treatment (antiviral drugs, microbiomemodulating therapy), the introduction of effective test systems for rapid diagnostics of NVI into routine practice, as well as genetic and immunological studies that will help to establish the subtle mechanisms of susceptibility to norovirus and the characteristics of the immune response to it. Key words: acute norovirus gastroenteritis, norovirus infection, dehydration, rehydration therapy, intestinal microbiome, probiotics, Saccharomyces boulardii CNCM I-745, children
- Open Access
- 15 December 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 342-348
Consensus resolution on the antipyretic therapy in ARI in children over 3 years. July 4, 2024, Vladimir; October 5–6, 2024, Kislovodsk
Every year, a seasonal increase in the incidence of respiratory infections is registered in the Russian Federation, primarily among children. It significantly increases the burden on the outpatient pediatric service. It is especially important to optimize the daily practice of pediatricians by developing algorithms and updating treatment protocols, as well as creating and conducting training programs. Fever is a leading symptom in acute respiratory viral infections and one of the most common reasons for seeking help in outpatient pediatric services. Leading experts in the field of therapy of respiratory infections in pediatrics have repeatedly discussed the problems of management of feverish children with acute respiratory infections, routing, personalized choice of therapy regimens at the outpatient stage of medical care. As a result, a number of positions concerning the individual use of antipyretic drugs in children over 3 years of age were agreed upon, “alarming” symptoms requiring immediate assistance/hospitalization were listed, and an algorithm for prescribing antipyretic therapy in children over 3 years of age was agreed upon.
- 15 December 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 342-348
Open AccessConsensus resolution on the antipyretic therapy in ARI in children over 3 years. July 4, 2024, Vladimir; October 5–6, 2024, Kislovodsk
Every year, a seasonal increase in the incidence of respiratory infections is registered in the Russian Federation, primarily among children. It significantly increases the burden on the outpatient pediatric service. It is especially important to optimize the daily practice of pediatricians by developing algorithms and updating treatment protocols, as well as creating and conducting training programs. Fever is a leading symptom in acute respiratory viral infections and one of the most common reasons for seeking help in outpatient pediatric services. Leading experts in the field of therapy of respiratory infections in pediatrics have repeatedly discussed the problems of management of feverish children with acute respiratory infections, routing, personalized choice of therapy regimens at the outpatient stage of medical care. As a result, a number of positions concerning the individual use of antipyretic drugs in children over 3 years of age were agreed upon, “alarming” symptoms requiring immediate assistance/hospitalization were listed, and an algorithm for prescribing antipyretic therapy in children over 3 years of age was agreed upon.
- 22 February 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (1)
Congenital and acquired forms of cytomegalovirus infection in infants
- 22 February 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (1)
Congenital and acquired forms of cytomegalovirus infection in infants
- Open Access
- 8 November 2023
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 27 (3) , 5-11
The problem of toxoplasmosis in outpatient practice. Part III. Toxoplasmosis in pregnants and congenital toxoplasmosis
Congenital toxoplasmosis is a consequence of acute toxoplasmosis in a pregnant woman. When assessing the risk of сongenital toxoplasmosis during pregnancy, methods for determining specific antibodies, the genetic material of the pathogen (polymerase chain reaction method), immunoglobulins G avidity are used. Molecular genetic methods have the greatest diagnostic value in the diagnosis of сongenital toxoplasmosis in children of the first year of life. Drug prevention of сongenital toxoplasmosis in Russia can be implemented with the use of spiramycin, antenatal therapy is impossible, and postnatal therapy is limited by the list of available antiprotozoal drugs. For the prevention of сongenital toxoplasmosis, the awareness of the population about the ways and factors of transmission of the pathogen is of primary importance.
- 8 November 2023
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 27 (3) , 5-11
Open AccessThe problem of toxoplasmosis in outpatient practice. Part III. Toxoplasmosis in pregnants and congenital toxoplasmosis
Congenital toxoplasmosis is a consequence of acute toxoplasmosis in a pregnant woman. When assessing the risk of сongenital toxoplasmosis during pregnancy, methods for determining specific antibodies, the genetic material of the pathogen (polymerase chain reaction method), immunoglobulins G avidity are used. Molecular genetic methods have the greatest diagnostic value in the diagnosis of сongenital toxoplasmosis in children of the first year of life. Drug prevention of сongenital toxoplasmosis in Russia can be implemented with the use of spiramycin, antenatal therapy is impossible, and postnatal therapy is limited by the list of available antiprotozoal drugs. For the prevention of сongenital toxoplasmosis, the awareness of the population about the ways and factors of transmission of the pathogen is of primary importance.
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 12 (2)
Lesions of organs and systems in children born from mothers with acute cytomegalovirus infection
Поражения органов и систем у детей, родившихся от матерей с острой цитомегаловирусной инфекцией
- 1 January 2023
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 12 (2)
Open AccessLesions of organs and systems in children born from mothers with acute cytomegalovirus infection
Поражения органов и систем у детей, родившихся от матерей с острой цитомегаловирусной инфекцией
- Open Access
- 13 September 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 29 (3) , 118-124
Clinical and laboratory characteristics of haemophilus influenza type b Infection with central nervous system Involvement in young children
Introduction. Invasive Haemophilus influenza type b (Hib) infection often manifests as severe and complicated forms of purulent meningitis in children from birth to 6 years of age. Hib meningitis is the most commonly diagnosed invasive form, with a severe course. There is no generally accepted clinical classification of Hib infection. Along with meningitis, the infection is often manifested with purulent inflammatory foci of different localization.The objective was to characterize the course of purulent Hib meningitis, including in combination with purulent foci, in young children.Methods and materials. We analyzed 45 case histories of children (under the age of 3 years) who had an invasive Haemophilus infection with purulent meningitis. Hib meningitis (Group-1) was diagnosed in 17 patients and meningitis in combination with specific purulent foci was diagnosed in 28 patients (Group-2). The diagnosis in all patients was confirmed bacteriologically or serologically (Latex Agglutination Test).Results. The combination of meningitis with purulent foci of Hib infection was characterized by late hospitalization (36 %), longer recovery of cerebrospinal fluid, longer duration of the disease, and the prevalence of severe and complicated disease, and often required surgical treatment (46.4 %). A burdened premorbid background is traditionally considered a condition for the development of invasive Hib infection. According to our data, only 40 % of children had a burdened premorbid background, which is confirmed by clinical cases.Conclusion. Since Hib infection in young children is often combined with meningitis with purulent foci, is characterized by a severe and complicated course, and often requires surgical treatment, it is advisable to consider this form of infection separately.
- 13 September 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 29 (3) , 118-124
Open AccessClinical and laboratory characteristics of haemophilus influenza type b Infection with central nervous system Involvement in young children
Introduction. Invasive Haemophilus influenza type b (Hib) infection often manifests as severe and complicated forms of purulent meningitis in children from birth to 6 years of age. Hib meningitis is the most commonly diagnosed invasive form, with a severe course. There is no generally accepted clinical classification of Hib infection. Along with meningitis, the infection is often manifested with purulent inflammatory foci of different localization.The objective was to characterize the course of purulent Hib meningitis, including in combination with purulent foci, in young children.Methods and materials. We analyzed 45 case histories of children (under the age of 3 years) who had an invasive Haemophilus infection with purulent meningitis. Hib meningitis (Group-1) was diagnosed in 17 patients and meningitis in combination with specific purulent foci was diagnosed in 28 patients (Group-2). The diagnosis in all patients was confirmed bacteriologically or serologically (Latex Agglutination Test).Results. The combination of meningitis with purulent foci of Hib infection was characterized by late hospitalization (36 %), longer recovery of cerebrospinal fluid, longer duration of the disease, and the prevalence of severe and complicated disease, and often required surgical treatment (46.4 %). A burdened premorbid background is traditionally considered a condition for the development of invasive Hib infection. According to our data, only 40 % of children had a burdened premorbid background, which is confirmed by clinical cases.Conclusion. Since Hib infection in young children is often combined with meningitis with purulent foci, is characterized by a severe and complicated course, and often requires surgical treatment, it is advisable to consider this form of infection separately.
- Open Access
- 10 December 2021
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 20 (4) , 47-52
Congenital herpes simpleх: modern approach to prevention, diagnosis, and treatment
Among the classic pathogens of congenital infection, herpes simplex viruses type 1 and type 2 play important role. Neonatal herpes develops as a result of antenatal transmission of HSV. The greatest risk occurs with the primary infection of a woman in the late stages of pregnancy. In 85% of cases, genital and neonatal herpes is associated with HSV-2.The purpose of study: to identify the relationship between early manifestations of neonatal herpes and genital herpes during pregnancy for early diagnosis and etiological therapy of the newborn.Materials and methods. The analysis of current clinical recommendations and international consensuses of professional communities in Russia, the USA, and a number of European countries in the management of pregnant women was carried out. The five medical histories of newborn infants with a diagnosis of congenital herpetic infection were analyzed. In the clinical guidelines for the management of normal pregnancy, routine screening of pregnant women for HSV is omitted, however, examination is recommended for symptoms of genital herpes. For the prevention of neonatal herpes, antiviral drugs and caesarean section are used. Congenital herpes develops rarely, proceeds severely with significant residual manifestations in children. Antiviral therapy (Acyclovir) is used for herpetic infection in newborns: with systemic and local infection (eye damage). The analysis showed: despite the recurrent course of genital herpes in 4 out of 5 women during pregnancy, none of the pregnant women had a laboratory examination for HSV, pregnant women did not receive systemic etiological therapy and all deliveries were natural. The absence of preventive measures contributed to the early, during the first three days of life, the development of severe forms of neonatal herpes. In respect that the lack of significant clinical specificity and delayed manifestation, an antenatal anamnesis is important diagnostic criterion for neonatal herpes.
- 10 December 2021
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 20 (4) , 47-52
Open AccessCongenital herpes simpleх: modern approach to prevention, diagnosis, and treatment
Among the classic pathogens of congenital infection, herpes simplex viruses type 1 and type 2 play important role. Neonatal herpes develops as a result of antenatal transmission of HSV. The greatest risk occurs with the primary infection of a woman in the late stages of pregnancy. In 85% of cases, genital and neonatal herpes is associated with HSV-2.The purpose of study: to identify the relationship between early manifestations of neonatal herpes and genital herpes during pregnancy for early diagnosis and etiological therapy of the newborn.Materials and methods. The analysis of current clinical recommendations and international consensuses of professional communities in Russia, the USA, and a number of European countries in the management of pregnant women was carried out. The five medical histories of newborn infants with a diagnosis of congenital herpetic infection were analyzed. In the clinical guidelines for the management of normal pregnancy, routine screening of pregnant women for HSV is omitted, however, examination is recommended for symptoms of genital herpes. For the prevention of neonatal herpes, antiviral drugs and caesarean section are used. Congenital herpes develops rarely, proceeds severely with significant residual manifestations in children. Antiviral therapy (Acyclovir) is used for herpetic infection in newborns: with systemic and local infection (eye damage). The analysis showed: despite the recurrent course of genital herpes in 4 out of 5 women during pregnancy, none of the pregnant women had a laboratory examination for HSV, pregnant women did not receive systemic etiological therapy and all deliveries were natural. The absence of preventive measures contributed to the early, during the first three days of life, the development of severe forms of neonatal herpes. In respect that the lack of significant clinical specificity and delayed manifestation, an antenatal anamnesis is important diagnostic criterion for neonatal herpes.
- Open Access
- 16 January 2020
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 64 (6) , 89-93
Ante- and postnatal diagnostics and complex treatment of congenital cytomegalovirus infection
Timely diagnostics and treatment of cytomegalovirus infection in pregnant women and newborns allow to avoid serious consequences, preserving the life and health of the child. The article provides an example of antenatal diagnosis of congenital cytomegalovirus infection in the fetus (positive result of polymerase chain reaction in umbilical cord blood), treatment with umbilical transfusion of donor red blood cells, postnatal therapy with antiviral drugs, including ganciclovir and specific immunoglobulin. The issues of assessing the risk of congenital cytomegalovirus infection, approaches to its prevention and treatment during pregnancy are discussed.
- 16 January 2020
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 64 (6) , 89-93
Open AccessAnte- and postnatal diagnostics and complex treatment of congenital cytomegalovirus infection
Timely diagnostics and treatment of cytomegalovirus infection in pregnant women and newborns allow to avoid serious consequences, preserving the life and health of the child. The article provides an example of antenatal diagnosis of congenital cytomegalovirus infection in the fetus (positive result of polymerase chain reaction in umbilical cord blood), treatment with umbilical transfusion of donor red blood cells, postnatal therapy with antiviral drugs, including ganciclovir and specific immunoglobulin. The issues of assessing the risk of congenital cytomegalovirus infection, approaches to its prevention and treatment during pregnancy are discussed.
- 10 June 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (3)
LATE MANIFESTATION OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN A CHILD WITH PRIMARY IMMUNODEFICIENCY
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.
- 10 June 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (3)
LATE MANIFESTATION OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN A CHILD WITH PRIMARY IMMUNODEFICIENCY
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.